Aspirin and the prevention of colorectal cancer

Affiliations

Comment

Thomas F Imperiale. N Engl J Med. 2003.

. 2003 Mar 6;348(10):879-80.

doi: 10.1056/NEJMp030005.

¹ Indiana University School of Medicine, the Roudebush Veterans Affairs Medical Center, and the Regenstrief Institute, Indianapolis, USA.

No abstract available

Comment on

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, Steinbach G, Schilsky R. Sandler RS, et al. N Engl J Med. 2003 Mar 6;348(10):883-90. doi: 10.1056/NEJMoa021633. N Engl J Med. 2003. PMID: 12621132 Clinical Trial.
A randomized trial of aspirin to prevent colorectal adenomas.
Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, Snover DC, Church TR, Allen JI, Beach M, Beck GJ, Bond JH, Byers T, Greenberg ER, Mandel JS, Marcon N, Mott LA, Pearson L, Saibil F, van Stolk RU. Baron JA, et al. N Engl J Med. 2003 Mar 6;348(10):891-9. doi: 10.1056/NEJMoa021735. N Engl J Med. 2003. PMID: 12621133 Clinical Trial.